The S&P BSE Sensex, was down 132.96 points or 0.23% to 57,488.23 and the Nifty 50 index lost 33.90 points or 0.20% to 17,179.70
The key Indian equity indices are trading lower in early trade amid volatility. The Nifty was trading below the 17,200 mark.
At 3:56 GMT, the barometer index, the S&P BSE Sensex, was down 132.96 points or 0.23% to 57,488.23. The Nifty 50 index lost 33.90 points or 0.20% to 17,179.70.
Maruti Suzuki (up 2.39%), Titan Company (up 1.09%), Eicher Motors (up 0.89%), Bajaj Finserv (up 0.87%) and Tata Steel (up 0.81%) were the top index gainers.
Tata Consumer (down 1.28%), SBI (down 0.97%), Power Grid Corp (down 0.80%), NTPC (down 0.79%) and ONGC (down 0.64%) were the top index losers.
In the broader market, the S&P BSE Mid-Cap index slipped 0.21% while the S&P BSE Small-Cap index declined 0.44%.
The market breadth was negative. On the BSE, 1,287 shares rose and 1,340 shares fell. A total of 101 shares were unchanged.
The Reserve Bank of India’s (RBI) Monetary Policy Committee (MPC) will meet on 8-10 February 2022. The RBI’s MPC will announce its interest rate decision on 10 February 2022.
TVS Motor Company advanced 3.60% to Rs 659.75 after the company posted an 8.5% increase in standalone net profit to Rs 288.31 crore on a 5.8% rise in net sales to Rs 5,706.43 crore in Q3 FY22 over Q3 FY21.
Biocon gained 0.64% to Rs 402.50. Biocon Pharma, a subsidiary of Biocon, received approval of its ANDA for Posaconazole Delayed-Release tablets from the US FDA. This product is indicated for use in the prevention of certain fungal infections in patients with severely weakened immune systems.
National Aluminium Company was up 0.08% to Rs 119.10. The company reported 246% surge in consolidated net profit to Rs 831 crore on 58.59% rise in total revenue to Rs 3773 crore in Q3 FY22 over Q3 F21.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.